Table 2.
OPAT Program Demographics
| Variable | Result |
|---|---|
| (N=27), No.(%) | |
| Pharmacist FTE dedicated to OPAT/COpAT, median (range) | 0.6 (0.2–1.0) |
| Patients enrolled in OPAT/COpAT, median (IQR) | 43 (10–65) |
| Reporting department | |
| Inpatient pharmacy | 20 (74.1) |
| Ambulatory pharmacy | 5 (18.5) |
| College of Pharmacy faculty | 3 (11.1) |
| Infectious diseases | 2 (7.4) |
| Pharmacists with a collaborative practice agreement of other license extension | 17 (63.0) |
| Pharmacists with job sharing with other infectious diseases functions | 22 (81.5) |
| Responsibility type | |
| Antimicrobial stewardship | 22 (81.5) |
| Inpatient infectious diseases consults | 16 (59.3) |
| Pharmacokinetic consults | 10 (37.0) |
| HIV clinic | 5 (18.5) |
| Hepatitis B or C clinic | 3 (11.1) |
| Other outpatient infectious diseases clinic | 6 (22.2) |
| OPAT clinic is a separate clinic from other outpatient infectious diseases clinics | 12 (44.4) |
| Pharmacists with an antimicrobial dispensing component | 3 (11.1) |
| Percentage of OPAT patients, median % (IQR) | 75 (50–95) |
| Frequency of OPAT patient follow-up | |
| Multiple times per week | 1 (3.8) |
| Weekly | 5 (19.2) |
| Every 2 weeks | 2 (7.7) |
| Monthly | 11 (42.3) |
| Other | 7 (26.9) |
| Missing | 1 |
| Percentage of COpAT patients, median % (IQR) | 10 (1–25) |
| Frequency of COpAT patient follow-up | |
| Multiple times per week | 1 (4.2) |
| Weekly | 2 (8.3) |
| Every 2 weeks | 4 (16.7) |
| Monthly | 8 (33.3) |
| Other | 9 (37.5) |
| Missing | 3 |
| Availability of follow-up as telemedicine | 19 (71.4) |
| Types of telemedicine | |
| Telephone or video conferencing | 11 (40.7) |
| Telephone only | 7 (25.9) |
| Video conferencing only | 1 (3.7) |
Note. FTE, full-time equivalent; OPAT, outpatient parenteral antimicrobial therapy; COpAT, complex outpatient antimicrobial therapy; IQR, interquartile range.